Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA from Lannett Company to market a generic Butalbital, Aspirin, and Caffeine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butalbital, Aspirin, and Caffeine (butalbital, aspirin, and caffeine)

Snippet

SUPPL AP for BUTALBITAL, ASPIRIN, AND CAFFEINE (BUTALBITAL, ASPIRIN, AND CAFFEINE)